<DOC>
	<DOC>NCT00163059</DOC>
	<brief_summary>To determine if the NMDA antagonist, CP-101,606, is effective for depression</brief_summary>
	<brief_title>The Antidepressant Effects Of The NMDA Antagonist, CP-101,606, In Patients With MDD</brief_title>
	<detailed_description />
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder, Major</mesh_term>
	<mesh_term>Antidepressive Agents</mesh_term>
	<criteria>Primary DSMIV diagnosis of MDD Subjects with evidence or history of clinically significant hematological, renal, endocrine, pulmonary, gastrointestinal, cardiovascular, hepatic, psychiatric, neurologic, or allergic disease (including drug allergies, but excluding untreated, asymptomatic, seasonal allergies at time of dosing).</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>September 2006</verification_date>
</DOC>